Skip to content

Rare Autosomal Trisomies Detected by Noninvasive Prenatal Testing: Performance, Outcomes, and Exploratory Analysis of the Theoretical Mosaicism Ratio.

Aug 2026 · Prenatal Diagnosis · 0 citations · 27 references
Medicine

TL;DR

RATs-positive NIPT results carried clinically meaningful pregnancy risk despite low fetal confirmation rates, and TMR was higher with adverse pregnancy outcomes, but overlap and poor receiver operating characteristic (ROC) performance limit standalone use.

Abstract

Objective

To characterize rare autosomal trisomies (RATs) detected by genome-wide noninvasive prenatal testing (GW-NIPT), evaluate their clinical significance, and explore whether sequencing-derived parameters are associated with adverse pregnancy outcomes.

Methods

This single-center retrospective cohort study included 64,889 singleton pregnancies undergoing GW-NIPT (March 2021-July 2024). RATs-positive cases were evaluated using invasive diagnostics, pregnancy outcomes, and sequence-derived markers, including a platform-specific theoretical mosaicism ratio (TMR).

Results

Of 112 RATs-positive pregnancies (0.17%), 79 underwent invasive diagnosis. Positive predictive value (PPV) for fetal confirmation was 5.1% (4/79) and diagnostic yield was 8.9% (7/79) when uniparental disomy/runs of homozygosity (UPD/ROH) findings were included. Follow-up of 104 pregnancies included 63 uncomplicated pregnancies, 34 adverse pregnancy outcomes, and 7 terminations of pregnancy (TOP). In the primary analysis of 93 pregnancies, the TMR showed poor discrimination for adverse outcomes (AUC 0.643, 95% CI 0.531-0.756). TMR ≥ 0.63 was associated with adverse outcomes after adjustment (adjusted OR 3.66, 95% CI 1.33-10.05; p = 0.012).

Conclusions

RATs-positive NIPT results carried clinically meaningful pregnancy risk despite low fetal confirmation rates. TMR was higher with adverse pregnancy outcomes, but overlap and poor receiver operating characteristic (ROC) performance limit standalone use. TMR should be supplementary, interpreted in the context of chromosome, diagnostic, ultrasound, and obstetric findings.

View source

Similar papers

Review Aug 2026

Prenatal diagnosis of large regions of homozygosity (ROH) in non-imprinted areas.

NIPT demonstrates potential for identifying ROH, and prenatal diagnostic indications, diagnostic results, and pregnancy outcomes associated with fetuses exhibiting large regions of homozygosity in non-imprinted regions are analyzed, ultimately providing a reference for related prenatal diagnosis and genetic counseling.

Qianzhu Jiang, Haihua Yu, Lin Yuan · 0 citations
Open access Sep 2026

Multimodal genomic testing in prenatal diagnosis: incremental diagnostic contribution of chromosomal microarray and exome sequencing, real-world NIPT confirmation rates and pregnancy outcomes in 120 consecutive amniocenteses from northeastern Türkiye — a retrospective cohort study

Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centr...

Çağrı Doğan, Selçuk Atalay, Hakan Timur · 0 citations
Aug 2026

Prenatal Genetic and Sonographic Features of KBG Syndrome: A Cohort Study of 19 Fetal Cases.

OBJECTIVE To characterize prenatal sonographic features, genomic findings from chromosomal microarray analysis (CMA) and whole-exome sequencing (WES), pregnancy outcomes, and postnatal manifestations in KBG syndrome and to provide evidence for prenatal diagnosis and genetic counseling in at-risk pregnancies. METHODS...

Xi Yang, Hongke Ding, Rong Hu et al. · 0 citations
Open access Aug 2026

Prenatal genetic findings and pregnancy outcomes in fetuses with congenital heart disease: a decade-long retrospective analysis at a tertiary hospital

Ultrasound findings suggest that genetic risk varies by CHD type, complexity, and extracardiac anomalies, which may inform more precise prenatal genetic risk stratification.

Qing-Cheng Chen, Longzhuang Peng, Youchun Cai et al. · 0 citations
Open access Sep 2026

Clinical utility of prenatal exome sequencing after normal chromosomal microarray in fetuses with structural anomalies.

Congenital anomalies detected by ultrasound occur in approximately 2-4% of pregnancies. Cytogenetic testing allows detection of chromosomal abnormalities, but the majority of fetuses remain without a diagnosis. It is in this context that exome sequencing was introduced into prenatal medicine. The objective of this stud...

M. Perrière, W. Darwiche, K. Messaoudi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.